DE1620053A1 - Purin-nucleoside und Verfahren zu deren Herstellung - Google Patents

Purin-nucleoside und Verfahren zu deren Herstellung

Info

Publication number
DE1620053A1
DE1620053A1 DE19661620053 DE1620053A DE1620053A1 DE 1620053 A1 DE1620053 A1 DE 1620053A1 DE 19661620053 DE19661620053 DE 19661620053 DE 1620053 A DE1620053 A DE 1620053A DE 1620053 A1 DE1620053 A1 DE 1620053A1
Authority
DE
Germany
Prior art keywords
methyl
hours
alkyl
solution
tri
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19661620053
Other languages
German (de)
English (en)
Inventor
Edward Walton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE1620053A1 publication Critical patent/DE1620053A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE19661620053 1965-11-15 1966-11-14 Purin-nucleoside und Verfahren zu deren Herstellung Pending DE1620053A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50771865A 1965-11-15 1965-11-15

Publications (1)

Publication Number Publication Date
DE1620053A1 true DE1620053A1 (de) 1970-03-12

Family

ID=24019834

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19661620053 Pending DE1620053A1 (de) 1965-11-15 1966-11-14 Purin-nucleoside und Verfahren zu deren Herstellung

Country Status (5)

Country Link
CH (1) CH490395A (enExample)
DE (1) DE1620053A1 (enExample)
FR (1) FR1504091A (enExample)
GB (1) GB1163103A (enExample)
NL (1) NL6615905A (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094770B2 (en) 2000-04-13 2006-08-22 Pharmasset, Ltd. 3′-or 2′-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
CZ301182B6 (cs) 2000-05-26 2009-12-02 Idenix (Cayman) Limited Použití nukleosidových derivátu pro výrobu farmaceutických prostredku pro lécení infekcí vyvolaných flaviviry a pestiviry
WO2003026589A2 (en) 2001-09-28 2003-04-03 Idenix (Cayman) Limited Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
KR20050055630A (ko) * 2002-06-28 2005-06-13 이데닉스 (케이만) 리미티드 플라비비리다에 감염 치료를 위한 1'-, 2'- 및 3'-변형된뉴클레오시드 유도체
WO2004002422A2 (en) 2002-06-28 2004-01-08 Idenix (Cayman) Limited 2’-c-methyl-3’-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
CN101172993A (zh) 2002-06-28 2008-05-07 埃迪尼克斯(开曼)有限公司 用于治疗黄病毒感染的2′－c－甲基－3′－o－l－缬氨酸酯核糖呋喃基胞苷
ES2624353T3 (es) 2002-11-15 2017-07-13 Idenix Pharmaceuticals Llc 2'-Metil nucleósidos en combinación con interferón y mutación de Flaviviridae
JP5254033B2 (ja) 2005-12-23 2013-08-07 イデニク プハルマセウティカルス，インコーポレイテッド 分岐型ヌクレオシドを調製するための合成中間体の製造方法

Also Published As

Publication number Publication date
CH490395A (de) 1970-05-15
FR1504091A (fr) 1967-12-01
NL6615905A (enExample) 1967-05-16
GB1163103A (en) 1969-09-04

Similar Documents

Publication Publication Date Title
DE3026172C2 (enExample)
DE69029733T2 (de) Nukleosidderivate von 2-halo-9(2-oxy-2-fluoro-beta-d-arabinofuranosyl)adenin
DE1620053A1 (de) Purin-nucleoside und Verfahren zu deren Herstellung
DE2056327C2 (de) 2,6-Diamino-9-(β-D-arabinofuranosyl)-purin, dessen N-6-Niedrigalkylderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten
DE2049638A1 (de) Isomere Nukleosiddenvate und Ver fahren zu ihrer Herstellung
CH634310A5 (de) Verfahren zur herstellung neuer pyrimidonderivate.
DE2160104A1 (de) Nucleosidderivate der purinreihe
DE2652391C3 (de) Daunosaminylanthracyclinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1620694B2 (de) Verfahren zur Herstellung von 5-Methyl-7-diäthylamino-s-triazolo [1,5-a] pyrimidin und seinen Salzen mit Säuren
DE1695411A1 (de) Substituierte Purin-Nucleoside und Verfahren zu deren Herstellung
DE2009834A1 (de) Neue Verbindungen und Verfahren zu ihrer Herstellung
Yamazaki et al. Synthesis of guanosine and its derivatives from 5-amino-1-. beta.-D-ribofuranosyl-4-imidazolecarboxamide. II. Ring closure with sodium methyl xanthate
DE3940021C2 (de) Adenosin-Derivate, deren Herstellung und Verwendung
Kazimierczuk et al. Methylation of adenosine in strongly alkaline medium: Preparation and Properties of o'-methyl derivatives of adenosine and N6-methyladenosine
DE2721466A1 (de) Verfahren zur herstellung von 2'-desoxyribofuranosylnucleosiden
DE1913384C2 (de) 1-(2',3'-Didesoxy-3'-fluor-β-D-xylofuranosyl)-thymin, Verfahren zu seiner Herstellung und dieses enthaltende Cytostatica
CH632748A5 (de) Verfahren zur herstellung von uracilderivaten.
DE2626792A1 (de) Acylderivate von adenosin-5'-monophosphorsaeure, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
WO2006120472A2 (en) Novel beta-steroid compounds
DE2342479A1 (de) Ribonucleosid-5'-nitrate und verfahren zu ihrer herstellung
AU684604B2 (en) Monohydrate of (E)-2'-deoxy-2'-(fluoromethylene)cytidine
DE2218221A1 (de) Verfahren und Zwischenprodukte zur Herstellung von 2.4-Diamino-5-benzylpyrimidinen
CN105037398B (zh) 一种Bcr‑Abl双倍体抑制剂及其制备方法和用途
Goldman et al. The Synthesis of Analogs of the Aminonucleoside from Puromycin1: 3'-Amino-3'-deoxyinosine and 2, 3'-Diamino-3'-deoxyadenosine2
DE1962261C3 (de) Verfahren zur Herstellung von 2,6- Bis-(diäthanolamino)-4,8-dipiperidinopyrimido[5,4-d]pyrimidin